ClinicalTrials.govpublic full text
Study of Novel Regimens in Relapsed or Refractory Multiple Myeloma
multiple myeloma, eos884448, gsk4428859a, tigit, anti-tigit, iberdomide, celmod, cc-220, eos-448, belrestotug, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 830778
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.